Science|Business
Policy Analysis: Life Sciences, Policy
Horizon 2020 Special Coverage
The Innovation Connection - The 2014 Science|Business Summit
The 2014 Science|Business Summit will bring together leaders from research, industry and policy to debate current future trends needed to unleash Europe's technological potential.
Berlin - 07 October 2014
So you want to start a company?
A workshop on forming a university spin-out company. Jointly organised by Science|Business and ASTP Proton as part of the ESOF conference.
Copenhagen - 25 June 2014
ACES Selection Committee
The Academic Enterprise Awards (ACES) Selection Committee meets to short list the finalists of the 2014 awards.
Copenhagen - 23 June 2014
The value(s) of science
With Europe’s biggest-ever research programme, Horizon 2020, now underway, Science|Business gathered several leaders in European research, industry and policy to debate the ethical questions that may arise. Their reflections, gathered here, are part of a Science|Business effort...
Published:
EU-US plans for joint funding of rare diseases research unveiled to industry

A new transatlantic alliance showcased its ambition to develop diagnostics for 8,000 rare diseases and double the number of registered Orphan drugs for rare conditions by 2020, at the Biotechnology Industry Organization (BIO) meeting in Washington


The European Commission's Director of Public Health Andrzej Rys said rare diseases will continue to be a priority in the next research programme, Horizon 2020 Photo: Charité, Berlin

The European Commission and the US National Institutes of Health (NIH) is putting together a jointly-funded programme of research to capitalise on advances in genomics and speed up the development of diagnostics and treatments for rare diseases.

The International Rare Disease Research Consortium (IRDiRC) set up by the Commission and the NIH to drive the plan, will hold a meeting in Montreal, Canada in October to finalise its research agenda, following two earlier meetings to set objectives...

This page requires a Science|Business Network Membership

This page is available to Science|Business Network Members only. If you are already a member then please log in (above).

Note if you are only registered to receive our Bulletin, or have previously purchased an item from our store, this does not give you access to the full benefits of the site. Join Now and plug into the Science|Business Network to get full access to all our news, events and business opportunities.

Science|Business is the first independent media company that brings together researchers, investors and policy makers in the European innovation community. It does so with a top-quality team and unique network of Europe's leading scientific institutions, corporations, policy makers and IP and VC specialists.

Be where innovation begins – become a member. Click here to learn more.



Related subjects: Biotechnology, European Commission, European Union, USA, personalised healthcare

Advertisement